Safety and efficacy of dendritic cell-based immunotherapy DCVAC/OvCa added to first-line chemotherapy (carboplatin plus paclitaxel) for epithelial ovarian cancer: a phase 2, open-label, multicenter, randomized trial
=======================================================================================================================================================================================================================

* Lukas Rob
* David Cibula
* Pawel Knapp
* Peter Mallmann
* Jaroslav Klat
* Lubos Minar
* Pavel Bartos
* Josef Chovanec
* Petr Valha
* Marek Pluta
* Zdenek Novotny
* Jiri Spacek
* Bohuslav Melichar
* Dariusz Kieszko
* Jitka Fucikova
* Tereza Hrnciarova
* Roman Pawel Korolkiewicz
* Marek Hraska
* Jirina Bartunkova
* Radek Spisek